Simvastatin/Ezetimibe

DRUG3 trials

Sponsors

University of Virginia, dr.Frank L.J. Visseren, Seoul National University Hospital

Conditions

Metabolic SyndromePeripheral Artery DiseaseType 2 Diabetes Mellitus Without Insulin Treatment

Phase 4

The PostprAndial eNdothelial Function After Combination of Ezetimibe and simvAstatin Study

CompletedNCT00817843

dr.Frank L.J. VisserenMetabolic Syndrome

Start: 2009-04-30End: 2010-09-30Updated: 2013-01-09

Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes

Seoul National University HospitalType 2 Diabetes Mellitus Without Insulin Treatment

Start: 2010-09-30End: 2011-08-31Target: 132Updated: 2010-08-19

Unknown Phase

Comprehensive Magnetic Resonance of Peripheral Arterial Disease

CompletedNCT00587678

University of VirginiaPeripheral Artery Disease

Start: 2006-01-31End: 2009-10-31Updated: 2017-08-21

Related Papers

Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease.

2011-08-0121 citations

Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism.

2009-08-0198 citations